18566362. DRUG-ELUTING TUBES FOR IMPROVED PATIENT CARE simplified abstract (BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM)
Contents
DRUG-ELUTING TUBES FOR IMPROVED PATIENT CARE
Organization Name
BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM
Inventor(s)
Daniel Stromberg of Austin TX (US)
Austin Veith of Austin TX (US)
DRUG-ELUTING TUBES FOR IMPROVED PATIENT CARE - A simplified explanation of the abstract
This abstract first appeared for US patent application 18566362 titled 'DRUG-ELUTING TUBES FOR IMPROVED PATIENT CARE
The present invention introduces enhanced drug-eluting tube devices designed to deliver analgesics directly to internal discomfort sites, such as internal membranes and implant entry points. These tube devices can be reloaded with drugs in situ and feature lubricating coatings to reduce friction with internal membranes. Additionally, they include flexible regions to dampen force transmission to implanted sites, preventing inadvertent pulling.
- Drug-eluting tube devices for targeted analgesic delivery
- Ability to reload drugs in situ
- Lubricating coatings to reduce friction with internal membranes
- Flexible regions to dampen force transmission to implanted sites
- Targeting internal discomfort sites such as internal membranes and implant entry points
Potential Applications: - Pain management in medical procedures - Post-operative care for implant patients - Targeted drug delivery in specific internal areas
Problems Solved: - Targeted delivery of analgesics to internal discomfort sites - Reduction of friction and pain during drug delivery - Prevention of inadvertent pulling on implanted sites
Benefits: - Enhanced pain management - Improved patient comfort during medical procedures - Targeted drug delivery for more effective treatment
Commercial Applications: Title: Enhanced Drug-Eluting Tube Devices for Targeted Pain Management This technology can be utilized in medical settings for pain management during procedures, post-operative care, and targeted drug delivery. The market implications include improved patient outcomes and increased efficiency in drug delivery processes.
Prior Art: Readers can explore prior art related to drug-eluting devices, targeted drug delivery systems, and pain management technologies in medical literature and patent databases.
Frequently Updated Research: Stay informed on the latest advancements in drug-eluting devices, targeted drug delivery systems, and pain management technologies through medical journals and research publications.
Questions about Drug-Eluting Tube Devices: 1. How do drug-eluting tube devices differ from traditional drug delivery methods? - Drug-eluting tube devices offer targeted delivery of analgesics to specific internal sites, providing more effective pain management compared to systemic drug administration.
2. What are the potential challenges associated with reloading drugs in situ with tube devices? - Challenges may include ensuring proper dosing, preventing contamination, and maintaining sterility during the reloading process.
Original Abstract Submitted
The present invention provides improved drug-eluting tube devices. In some embodiments, the tube devices deliver analgesics directly at sites of internal discomfort, including, but not limited to, internal membranes and implant entry sites. In some embodiments, the tube devices can be reloaded with drug in situ. In some embodiments, the tube devices comprise lubricating coatings to reduce painful friction with internal membranes. In some embodiments, the tube devices further include flexible and pliable regions that dampen force transmission to implanted sites, such as by inadvertent pulling.
